Recent News

• 01.07.2025 - Donald Tang
• 01.06.2025 - Senti Bio Announces Additional $11.5 Million of Financing
• 12.16.2024 - Senti Bio Announces First Patient Dosed in Clinical Trial of SN301A in Hepatocellular Carcinoma in Collaboration with Celest Therapeutics

Recent Filings

• 02.06.2025 - 8-K Current report
• 02.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.27.2025 - DEF 14A Other definitive proxy statements
• 01.15.2025 - PRE 14A Other preliminary proxy statements
• 01.06.2025 - EX-99.1 EX-99.1
• 12.19.2024 - D Notice of Exempt Offering of Securities
• 12.10.2024 - 3 Initial statement of beneficial ownership of securities